{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:26:46Z","timestamp":1794857206955,"version":"4.9.1"},"reference-count":40,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2002,5,24]],"date-time":"2002-05-24T00:00:00Z","timestamp":1022198400000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2002,5]]},"abstract":"<jats:p><jats:bold>Summary:<\/jats:bold><jats:bold> \u2002Purpose: <\/jats:bold> Sulthiame is a carbonic anhydrase (CA) inhibitor with an anticonvulsant effect in the treatment of benign and symptomatic focal epilepsy in children. The aim of the study was to elucidate the mode of action of sulthiame with respect to possible changes of intracellular pH (pH<jats:sub>i<\/jats:sub>) that might develop along with sulthiame's anticonvulsant properties.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The effects of sulthiame (a) on pH<jats:sub>i<\/jats:sub> of 2\u2032,7\u2010bis(2\u2010carboxyethyl)\u20105(6)\u2010carboxyfluorescein\u2010acetoxymetyl ester (BCECF\u2010AM) loaded CA3 neurones as well as (b) on epileptiform activity (induced by 50 \u03bc<jats:italic>M<\/jats:italic> 4\u2010aminopyridine) were compared with those of the CA inhibitors acetazolamide and benzolamide.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In the majority of neurons, sulthiame (1.0\u20131.5 m<jats:italic>M;<\/jats:italic> n = 8) as well as the membrane permeant acetazolamide (0.5\u20131.0 m<jats:italic>M;<\/jats:italic> n = 6) reversibly decreased pH<jats:sub>i<\/jats:sub> by 0.18 \u00b1 0.05 (SD) and 0.17 \u00b1 0.10 (SD) pH units, respectively, within 10 min. The poor membrane permeant benzolamide (1.0\u20132.0 m<jats:italic>M<\/jats:italic>) had no influence on pH<jats:sub>i<\/jats:sub> (n = 8). Sulthiame (1.0\u20132.5 m<jats:italic>M<\/jats:italic>) and acetazolamide (1.0\u20132.0 m<jats:italic>M<\/jats:italic>) reversibly reduced the frequency of action potentials and epileptiform bursts after 10\u201315 min (n = 9, n = 7), whereas benzolamide (1.0\u20132.0 m<jats:italic>M<\/jats:italic>) had no effect (n = 6).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> The results suggest that sulthiame acts as a membrane\u2010permeant CA inhibitor whose beneficial effect on epileptiform activity results at least in part from a modest intracellular acidosis of central neurons.<\/jats:p>","DOI":"10.1046\/j.1528-1157.2002.32601.x","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T21:39:22Z","timestamp":1027892362000},"page":"469-474","source":"Crossref","is-referenced-by-count":79,"title":["Carbonic Anhydrase Inhibitor Sulthiame Reduces Intracellular pH and Epileptiform Activity of Hippocampal CA3\u2003Neurons"],"prefix":"10.1111","volume":"43","author":[{"given":"Tobias","family":"Leniger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wiemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Bingmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Widman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hufnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,5,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01486564"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb04606.x"},{"key":"e_1_2_5_4_2","first-page":"433","article-title":"Auch zur Behandlung nicht\u2010benigner fokaler Epilepsien.","volume":"47","author":"Korn\u2010Merker E","year":"1994","journal-title":"P\u00e4diatr Praxis"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979719"},{"key":"e_1_2_5_6_2","first-page":"542","article-title":"Sulthiame\u2010associated mild compensated metabolic acidosis.","volume":"34","author":"Troger U","year":"1996","journal-title":"Int J Clin Pharmacol Ther"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1967.47.4.595"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1933.sp003077"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1993.tb09553.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.1999.0505m.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0752212.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(90)90034-E"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(87)90112-1"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1988.sp016961"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)91447-9"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(92)90191-A"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1997.78.5.2582"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.36.22373"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)02350-7"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00341-2"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)01687-X"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(00)00033-2"},{"key":"e_1_2_5_23_2","first-page":"617","volume-title":"Antiepileptic drugs: mechanisms of action","author":"Woodbury DM","year":"1980"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1988.65.1.422"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1242\/jeb.156.1.349","article-title":"Effect of gamma\u2010aminobutyric acid on intracellular pH in the crayfish stretch\u2010receptor neurone.","volume":"156","author":"Voipio J","year":"1991","journal-title":"J Exp Biol"},{"key":"e_1_2_5_26_2","first-page":"383","article-title":"Selective renal carbonic anhydrase inhibition without respiratory effect: pharmacology of 2\u2010benzenesulfonamido\u20101,3,4\u2010thiadiazole\u20105\u2010sulfonamide (CL 11,366).","volume":"143","author":"Travis DM","year":"1964","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_5_27_2","first-page":"99","article-title":"Pharmacological inhibition of brain carbonic anhydrase protects against 4\u2010aminopyridine seizures.","volume":"82","author":"Mihaly A","year":"1994","journal-title":"Acta Physiol Hung"},{"issue":"7","key":"e_1_2_5_28_2","first-page":"34","article-title":"Carbonic anhydrase inhibitors sulthiame and acetazolamide: effects on neuronal activity and intracellular pH of CA3 neurones.","volume":"41","author":"Leniger T","year":"2000","journal-title":"Epilepsia"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1987.57.6.1911"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2000.00080.x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1096\/fasebj.10.10.8751723","article-title":"Superiority of in vitro over in vivo calibrations of BCECF in vascular smooth muscle cells.","volume":"10","author":"Boyarsky G","year":"1996","journal-title":"FASEB"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00238204"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(96)00029-5"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/9783527618330"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(01)02262-4"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-1136(200008)31:2<125::AID-GLIA40>3.0.CO;2-7"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-22-08247.2000"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1992.tb02181.x"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1998.80.4.1702"},{"key":"e_1_2_5_40_2","first-page":"417","volume-title":"pH and brain function","author":"Traynelis SF","year":"1998"},{"key":"e_1_2_5_41_2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/jn.1999.81.4.1839","article-title":"Modulation of N\u2010type Ca2+ channels by intracellular pH in chick sensory neurons.","volume":"81","author":"Kiss L","year":"1999","journal-title":"J Neurophysiol"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1528-1157.2002.32601.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1528-1157.2002.32601.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T05:22:00Z","timestamp":1697347320000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1528-1157.2002.32601.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["10.1046\/j.1528-1157.2002.32601.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1528-1157.2002.32601.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}